Efficacy and tolerability of tirzepatide, a dual glucosedependent insulinotropic peptide and glucagonlike peptide1 receptor agonist in patients with type 2 diabetes: a 12week, randomized, doubleblind, placebocontrolled study to evaluate different doseescalation regimens
Strive Compounding Pharmacy received formal disciplinary action from the Arizona State Board of Pharmacy in February 2024 for improper semaglutide compounding and inaccurate compounding records, resulting in a $1,000 civil penalty
You cannot win a battle against their willpower, so you must change the battlefield
Bowrey, Robyn M
Mounjaro contains tirzepatide, which acts on both GLP-1 and GIP receptors, potentially creating a different side effect profile. Clinical trial data from the FDA shows that eructation (burping) occurred in 2.7% of patients on Ozempic 0.5 mg and 1.1% on the 1 mg dose
GLP-1 Acid Reflux: Pepcid vs Prilosec: For comparing acid reducer options for reflux symptoms